Evidence map›Paper›PMID 29451838›Full record

SynthesisHuman vaccines & immunotherapeutics2018

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis.

Kaile Chen, Xiyan Zhang, Wei Shan, Genming Zhao, Tao Zhang

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Prevalence ofHuman vaccines & immunotherapeutics · 2024
    Pooled it
  3. Pooled it
  4. Article
  5. Prevalence and serotype distribution of nasopharyngeal carriage ofThe Lancet regional health. Western Pacific · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. [Dose-response relationship between age andZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  12. Effect of pneumococcal conjugate vaccine availability onEmerging microbes & infections · 2022
    Article
  13. Article
  14. Article
  15. Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaile Chena Department of Epidemiology , School of Public Health, Fudan University, Shanghai, China.
Xiyan Zhanga Department of Epidemiology , School of Public Health, Fudan University, Shanghai, China.
Wei Shana Department of Epidemiology , School of Public Health, Fudan University, Shanghai, China.
Genming Zhaoa Department of Epidemiology , School of Public Health, Fudan University, Shanghai, China.
Tao Zhanga Department of Epidemiology , School of Public Health, Fudan University, Shanghai, China.

Funding

CGH CDC HHS U2G GH000018
6 · The paper itself

Abstract

objectiveThirteen-valent pneumococcal conjugate vaccines (PCV13) was licensed for optional use in mainland China since 2017, but the uptake is low. To update the research evidence for the pneumococcal serotype distribution of pre-PCV era and to estimate the potential impact of PCVs, we performed a meta-analysis on the relevant publications concerning the Chinese population.

methodsThis systematic review and meta-analysis were conducted on the pneumococcal serotype distribution publications in mainland China from 2000 to 2016. The literature was searched in PubMed, Ovid-EMBASE, Web of Science, CNKI and Wanfang. Heterogeneity and publication bias were tested by I

resultsIn total, 85 publications were included. Of all 16,945 included pneumococcal isolates, the most common serotypes/serogroups were 19F, 19A, 23F, 14, and 6B, that from children were the same as above, that from adults≥18 years were 19, 3, 6, 23, and 14. Among isolates from children <18 years, the pooled coverage for PCV10 serotypes was 52.3%, that for PCV13 was 68.4% and that for PPSV23 was 65.5%. Regarding individuals ≥18 years, the pooled coverage for PCV10 serotypes was 29.7%, that for PCV13 was 49.5% and that for PPSV23 was 50.7%. Serotype prevalence and vaccine serotype coverage varied by age group, source, and region.

conclusionsThe most common pneumococcal serotype in mainland China was 19F. The serotype coverage rates of PCV13 and PPSV23 were 50%-68% in mainland China.

Indexed as

SerogroupAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFemaleHumansInfantInfant, NewbornMaleMiddle AgedPneumococcal InfectionsPneumococcal VaccinesPneumococcal VaccinesVaccines, ConjugateChinapneumococcal conjugate vaccinepneumococcal polysaccharide vaccineserotypeStreptococcus pneumoniae

Identifiers

PMID29451838
PMCPMC6037451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.